Top 17 ROME Therapeutics investors
The most complete profiles first. Showing 17 of 17.
Carol SuhVerified
Venture Capital, Investor · United States
Series BHealth CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
David CruikshankVerified
Venture Capital, Investor · United States
Series BHealth CareLife ScienceBiotechnologyHardwarePortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Krishna YeshwantVerified
Venture Capital, Corporate Venture Capital, Investor · United States
Series BHealth CareTelecommunicationsHospitalsE-commercePortfolio: Pixie, Dialpad, Science 37, Synack and 90 more
Verified email available
Meredith FisherVerified
Venture Capital, Investor · United States
SeedHealth CareWellnessWomen FoundedLife SciencePortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Verified email available
Roger KittermanVerified
Venture Capital, Investor · United States
SeedHealth CareWellnessWomen FoundedLife SciencePortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Verified email available
Sean KendallVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareEnterprise SoftwareEnergyChemicalPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Karim FarisVerified
Venture Capital, Corporate Venture Capital · United States
Health CareTelecommunicationsE-commerceConsumer GoodsPortfolio: Pixie, Dialpad, Science 37, Synack and 87 more
Verified email available
Mark McDonnellVerified
Venture Capital · United States
Health CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Tom BrennanVerified
Venture Capital, Private Equity Firm · United States
Health CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Carl Berke
Venture Capital, Investor · United States
SeedHealth CareWellnessWomen FoundedLife SciencePortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Contact details available
Corey Ritter
Venture Capital, Investor · United States
Series BHealth CareLife ScienceRoboticsManufacturingPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Contact details available
Nilay Thakar
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Contact details available
Steve Gillis
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 68 more
Contact details available
Julius Knowles
Venture Capital, Design Operator, Strategy Operator · United States
Health CareHospitalsWellnessWomen FoundedPortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Contact details available
Robert Nelsen
Venture Capital, Investor · United States
Health CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 78 more
Contact details available
Ruoxi Hu
Venture Capital · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Contact details available
Jim Trenkle, PhD
Venture Capital, Investor · United States
Series ABiotechnologyConsumer HealthElectronic Health Records (EHR)Health and Hospital ServicesPortfolio: Therini Bio, ROME Therapeutics
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many ROME Therapeutics investors are on Angel Roster?
Angel Roster lists 17 ROME Therapeutics investors. 9 of them (53%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (17), Private Equity Firms (4) and Corporate Venture Capital Firms (2). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do ROME Therapeutics investors invest in?
Among those that list a stage, the most common are Series B (7), Seed (3) and Series A (1).
Where are ROME Therapeutics investors based?
Most are based in the United States (16) and the United Kingdom (1).
Which companies have ROME Therapeutics investors backed?
The most-backed portfolio companies among them are LifeMine Therapeutics (11), Locanabio (11), Verve Therapeutics (11), Encodia (11) and Encoded Therapeutics (11).
How do I contact ROME Therapeutics investors?
Create a free Angel Roster account to search and filter all 17, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.